Review of Ayurvedic Drugs on Acid-peptic Diseases Regarding Its Personalized Management

Year : 2024 | Volume : 13 | Issue : 02 | Page : 24-38
    By

    Anshul,

  • Ravina Yadav,

  1. Associate Professor, Department of Panchkarma, GBAC, Rohtak, 124303., Haryana, India
  2. Assistant Professor, Department of Panchkarma, GBAC, Rohtak, 124303., Haryana, India

Abstract

Acid-peptic Disease (~Amlapitta) is an illness wide-spread all around the world. In Ayurveda, Vidahi (which cause burning) and Pitta (dosha responsible for metabolic activities) aggravating diet and stressful –sedentary life-style has been stated as one of the leading cause for acceleration of Amlapitta. Detailed reviewing of drugs given in Ayurvedic texts are done according to specific stage of disease, Amlapitta Dosha predominance, chronicity, associated conditions, dosage, Anupana etc. Screening the classical texts of Ayurveda extensively resulted in 85 formulations comprising different combinations as per Dosha and Vyadhi stages. These formulations were presented with different dosage forms such as Ghrita (9), Tail (1), Vati (10), Churna (11), Awaleha (16), decoction (16) and herbo-mineral(22)formulations. 63 herbal preparations were taken for analysis. Herbo-mineral drugs are excluded from analysis. Formulas can be varied according to requirement of personalized management as emphasized in Ayurveda. Generally, Tikta Rasa have Srotoshodhan and Pitta pacifying effect. Since disease has dominant association of Kapha and Pitta Dosha, so Tikta Rasa enriched drugs in combination with Deepan-pachan drugs are described along with some other drugs according to associated conditions. Dosage forms are also changed according to nature, chronicity of disease. Artificial intelligence tool can be implemented to prevent and manage this disease more specifically and error free according to various conditions like mode of action of drugs, percentage relief according to specific conditions etc.

Keywords: Ayurveda, acid-peptic disease, Amlapitta, Pachan, Srotoshodhan

[This article belongs to Journal of AYUSH: Ayurveda, Yoga, Unani, Siddha and Homeopathy ]

How to cite this article:
Anshul, Ravina Yadav. Review of Ayurvedic Drugs on Acid-peptic Diseases Regarding Its Personalized Management. Journal of AYUSH: Ayurveda, Yoga, Unani, Siddha and Homeopathy. 2024; 13(02):24-38.
How to cite this URL:
Anshul, Ravina Yadav. Review of Ayurvedic Drugs on Acid-peptic Diseases Regarding Its Personalized Management. Journal of AYUSH: Ayurveda, Yoga, Unani, Siddha and Homeopathy. 2024; 13(02):24-38. Available from: https://journals.stmjournals.com/joayush/article=2024/view=151791


References

  1. Shashtri Vidyotini Hindi Commentary on Yogratnakar Uttarardh, verse 31/01P.237. Varanasi: Chaukhambha Prakashan; 2015.
  2. Shashtri KN, Chaturvedi Vidyotini Hindi Commentary on Charak Samhita-II, Chikitsa sthan, Verse 115/44. Varanasi: Chaukhambha Bharti Academy; 2011. 460p.
  3. Anthony F, Dennis K, Stephen H, Dan L, Joseph L, Larry JJ. Harrison’s Principles of Internal Medicines, volume-II, Disorders of the Gastrointestinal Symptoms, 16th ed. USA: McGraw Hill Medical Publishing Division; 2005. 1742p.
  4. Anthony F, Dennis K, Stephen H, Dan L, Joseph L, Larry JJ. Harrison’s Principles of Internal Medicines volume-II, Disorders of the Gastrointestinal Symptoms, Chapter-274, 16th ed. USA: McGraw Hill Medical Publishing Division; 2005. 1760p.
  5. Anthony F, Dennis K, Stephen H, Dan L, Joseph L, Larry JJ. Harrison’s Principles of Internal Medicines volume-II, Disorders of the Gastrointestinal Symptoms, Chapter-274, 16th ed. USA: McGraw Hill Medical Publishing Division; 1736p.
  6. Anthony F, Dennis K, Stephen H, Dan L, Joseph L, Larry JJ. Harrison’s Principles of Internal Medicines volume-II, Disorders of the Gastrointestinal Symptoms, Chapter-329, 16th ed. USA: McGraw Hill Medical Publishing Division; 2227p.
  7. Anthony F, Dennis K, Stephen H, Dan L, Joseph L, Larry JJ. Harrison’s Principles of Internal Medicines volume-II, Disorders of the Gastrointestinal Symptoms, Chapter-274, 16th ed. USA: McGraw Hill Medical Publishing Division; 1742p.
  8. Mejia A, Kraft WK. Acid peptic diseases: pharmacological approach to treatment. Expert Review of Clinical Pharmacology. 2009; 2(3): 295–314p. doi:10.1586/ecp.09.8
  9. Sweis R, Fox M. The global burden of gastro-oesophageal reflux disease: more than just heartburn and regurgitation. The Lancet Gastroenterology & Hepatology. 2020; 5(6): 519–521p.
  10. Scholten T. Long-term management of gastroesophageal reflux disease with pantoprazole. Therapeutics and Clinical Risk Management. 2007; 3(2): 231–243p. doi:10.2147/tcrm.2007.3.2.231
  11. Kinoshita Y, Ishimura N, Ishihara S. Advantages and disadvantages of long-term proton pump inhibitor u Journal of Neurogastroenterology and Motility. 2018; 24(2): 182–196p. doi:10.5056/jnm18001
  12. Vaidya Shree Lakshmipati Shastri, edited by Brahamshankar shastri, Yogratnakar with Vidyotini hindi commentary, Amlapitta prakaran, verse 2. Varanasi: Chaukhamba Prakashan; reprint edition 2015. 240
  13. Shashtri KN, Chaturvedi Vidyotini Hindi Commentary on Charak Samhita-II, Chikitsa sthan, Verse 12/52. Varanasi: Chaukhambha Bharti Academy; 2011. 366p.
  14. Tripathi Chakradatta on Shri Chakrapani Datta, Vaidayaprabha Hindi Commentary, edited by Ramanath Dwivedy, Amlapitta Chikitsa prakaran, chapter 52, verse 07. Varanasi: Chaukhamba Sanskrit Bhawan; reprint edition 2015. 295p.
  15. Tripathi Chakradatta on Shri Chakrapani Datta, Vaidayaprabha Hindi Commentary, edited by Ramanath Dwivedy, Amlapitta Chikitsa Prakaran, chapter 52, verse 9. Varanasi: Chaukhamba Sanskrit Bhawan; reprint edition 2015. 295p.
  16. TripathiChakradatta on Shri Chakrapani Datta, Vaidayaprabha Hindi Commentary, edited by Ramanath Dwivedy, chapter 52, verse 26, Amlapitta Chikitsa prakaran. Varanasi: Chaukhamba Sanskrit Bhawan; reprint edition 2015. 297p.
  17. Tripathi Chakradatta on Shri Chakrapani Datta, Vaidayaprabha Hindi Commentary, edited by Ramanath Dwivedy, chapter 52, verse 17, Amlapitta Chikitsa prakaran. Varanasi: Chaukhamba Sanskrit Bhawan; reprint edition 2015. 296p.
  18. TripathiChakradatta on Shri Chakrapani Datta, Vaidayaprabha Hindi Commentary, edited by Ramanath Dwivedy, Amlapitta Chikitsa prakaran, chapter 52, verse 6. Varanasi: Chaukhamba Sanskrit Bhawan; reprint edition 2015. 295p.
  19. Sharma PH, editor. Kashyapa Samhita with Vidhyotini Hindi commentary. Khil Sthana, Chapter 16. Verse 44-48, 3rd ed. Varanasi: Chaukhamba Sanskrit Series Office; 2008. 335p.
  20. Tripathi Chakradatta on Shri Chakrapani Datta, Vaidayaprabha Hindi Commentary, edited by Ramanath Dwivedy, Amlapitta Chikitsa prakaran, chapter 52, verse 14. Varanasi: Chaukhamba Sanskrit Bhawan; reprint edition 2015. 296p.
  21. Tripathi Chakradatta on Shri chakrapani datta, Vaidayaprabha Hindi Commentary, edited by Ramanath Dwivedy, Amlapitta Chikitsa prakaran, chapter 52, verse 18. Varanasi: Chaukhamba Sanskrit Bhawan; reprint edition 2015. 296p.
  22. Tripathi Chakradatta on Shri Chakrapani Datta, Vaidayaprabha Hindi Commentary, edited by Ramanath Dwivedy, Amlapitta Chikitsa prakaran, chapter 52, verse 19. Varanasi: Chaukhamba Sanskrit Bhawan; reprint edition 2015. 297p.
  23. Tripathi ID. Chakradatta on Shri Chakrapani Datta, Vaidayaprabha Hindi Commentary, edited by Ramanath Dwivedy, Amlapitta Chikitsa prakaran, chapter 52, verse 13. Varanasi: Chaukhamba Sanskrit Bhawan; reprint edition 2015. 296
  24. Tripathi Chakradatta on Shri Chakrapani Datta, Vaidayaprabha Hindi Commentary, edited by Ramanath Dwivedy, Amlapitta Chikitsa prakaran, chapter 52, verse 12. Varanasi: Chaukhamba Sanskrit Bhawan; reprint edition 2015. 296p.
  25. Vaidya Shree Lakshmi Pati Shastri, edited by Brahamshankar Shastri, Yogratnakar with Vidyotini hindi commentary, Amlapitta prakaran, verse 3. Varanasi: Chaukhamba Prakashan; reprint edition 2015. 240
  26. Tripathi Chakradatta on Shri Chakrapani Datta, Vaidayaprabha Hindi Commentary, edited by Ramanath Dwivedy, Amlapitta Chikitsa prakaran, chapter 52, verse 10. Varanasi: Chaukhamba Sanskrit Bhawan; reprint edition 2015. 296p.
  27. Tripathi Chakradatta on Shri Chakrapani Datta, Vaidayaprabha Hindi Commentary, edited by Ramanath Dwivedy, Amlapitta Chikitsa prakaran, chapter 52, verse 15. Varanasi: Chaukhamba Sanskrit Bhawan; reprint edition 2015. 296p.
  28. Tripathi Chakradatta on Shri Chakrapani Datta, Vaidayaprabha Hindi Commentary, edited by Ramanath Dwivedy, Amlapitta Chikitsa prakaran, chapter 52, verse 11. Varanasi: Chaukhamba sanskrit Bhawan; reprint edition 2015. 296p.
  29. Tripathi Chakradatta on Shri Chakrapani Datta, Vaidayaprabha Hindi Commentary, edited by Ramanath Dwivedy, Amlapitta Chikitsa prakaran, chapter 52, verse 20. Varanasi: Chaukhamba Sanskrit Bhawan; reprint edition 2015. 297p.
  30. Tripathi Chakradatta on Shri Chakrapani Datta, Vaidayaprabha Hindi Commentary, edited by Ramanath Dwivedy, Amlapitta Chikitsa prakaran, chapter 52, verse 27-28. Varanasi: Chaukhamba Sanskrit Bhawan; reprint edition 2015. 297p.
  31. Tripathi Chakradatta on Shri Chakrapani Datta, Vaidayaprabha Hindi Commentary, edited by Ramanath Dwivedy, Amlapitta Chikitsa prakaran, chapter 52, verse 8. Varanasi: Chaukhamba Sanskrit Bhawan; reprint edition 2015. 295p.
  32. Baragi UC, Vyas M Clinical evaluation of the efficacy of Dashanga Kwatha Ghana Vati in the management of Urdhwaga Amlapitta (Non-ulcer dyspepsia). Ayu. 2012; 33(2): 219–223p. Available from: https://doi.org/10.4103/0974-8520.105241
  33. Mithun K, Bhat KR. A comparative clinical study on the effectiveness OF vasadi dashanga kwatha and patoladi kwatha in amlapitta (non ulcer dyspepsia). International Journal of Ayurveda and Pharma Research. 2020; 8(10): 29–37p. Available from: https://doi.org/10.47070/ijapr.v8i10.1635
  34. Anshul, Srivastava AK, Rohilla P. Randomized parallel group clinical trial to evaluate the efficacy of Virechana Karma and Khanda Pippali Avaleha in Amlapitta. Journal of Ayurveda and Integrated Medical Sciences. 2021; 6(1): 1–7p. Available from: https://doi.org/10.21760/jaims.v6i01.1174
  35. Yadav D. A comparative clinical management of amlapitta (gastritis) with khanda kushmanda avaleha and narikela khanda avaleha. WJPR. 2020; 9(1): 1943–1951p. Available from: https://wjpr.net/abstract_file/13721
  36. Pramod B, Patgiri BJ, Prajapati P, Ravishankar B. Anti ulcer activity of Narikela Khanda and Narikela Khanda granules. Ayu. 2009; 30(4): 484–488p. Available from: https://www.ayujournal.
    org/temp/Ayu304484-4795168_131911.pdf
  37. Ghosh K, Baghel MS. A clinical study to evaluate the role of Doshik predominance in the management of Amlapitta. Ayu. 2017; 38(1–2): 15–23p. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954255/
  38. Suryawanshi VAR, Manwatkar VMN, Kulkarni VPV. Systemic review and analysis of research on Amlapitta. J Ayurveda Integr Med Sci. 2020; 5(3): 112–115p. Available from: https://www.jaims.
    in/jaims/article/view/920/938.
  39. Patil A, Jibi A comparative clinical study of Yavadi Ghana Vati and Guduchyadi Ghana Vati in the agement of Amlapitta. IAMJ. 2012; 3(2): 369–374p. Available from: https://1library.net/document/zwkkje0z-comparative-clinical-study-yavadi-ghana-guduchyadi-management-amlapitta.html
  40. Solanki UN, Parmar DK. Comparative Clinical Efficacy of Guduchyadi Syrup and Guduchyadi Ghanvati in Management of Amlapitta. IJAM. 2020; 11(2): 261–264p. Available from: https://www.ijam.co.in/index.php/ijam/article/view/1467.
  41. Yadav AS. Study of therapeutic effect of Kushmand Khanda in Urdhwaga Amlapitta: Randomize Clinical Trial. IJ-RIM. 2020; 4(6): 1–6p. Available from: https://www.ayurline.in/index.php/ayurline/article/view/464
  42. Chaitrika H, Belavadi S Comparative effect of Khandamalaki Rasayana and Gudakushmandaka Rasayana in Urdwaga Amlapitta. IJAPR. 2021; 9(10): 25–30p. Available from: https://ijapr.in/index.php/ijapr/article/view/2147/1460.
  43. Nagalakshmi AS, Muralidhara, Vijayalakshmi S. A comparative clinical study to evaluate the efficacy of patoladi kwatha and paaribhadradi kwatha in the management of Amlapitta. EJPMR. 2020; 7(11): 810–814p. Available from: https://storage.googleapis.com/journal-uploads/ejpmr/article_issue/1604487113.pdf
  44. Prajapati SM, Patel BR. A comparative clinical study of Jethimala (Taverniera nummularia Baker.) and Yashtimadhu (Glycyrrhiza glabra Linn.) in the management of Amlapitta. Ayu. 2015; 36(2): 157–162p. Available from: https://pubmed.ncbi.nlm.nih.gov/27011716/
  45. Chhimpa DR, Mothaliya DK, Dadhich POP. Clinical Study of khandakushmanda Avaleha And Patoladi kwatha on Amlapitta w.s.r. GERD (Acidity) – A Pilot Study. International Research Journal of Ayurveda & Yoga. 2021; 4(1): 33–47p. Available from: https://irjay.com/index.php/irjay/article/view/393.
  46. Damba B, Joshi PV, Venkatesh A placebo controlled double blind comparative clinical study to evaluate the efficacy of katuki and sita churna in urdhvaga amlapitta. Ayushdhara. 2019; 6(2): 2102–2107p. Available from: https://ayushdhara.in/index.php/ayushdhara/article/view/447
  47. Dipanjan J, Belavadi SN, Hazera K. Evaluation of efficacy of arohanakrama snehapana and virechana in the management of Adhogaamlapitta. Int J Ayu Pharm Res. 2018; 6(10): 1–8p. Available from: https://ijapr.in/index.php/ijapr/article/view/1063
  48. Choudari SM, Kulkarni RR, Joshi PV. A placebo controlled comparative clinical study to evaluate the efficacy of Jeerakadya Ghrita Prayoga in Amlapitta with special referance to Urdhvaga Amlapitta. International Ayurvedic Medical Journal. 2020; 1(8): 2563–2569p. Available from: http://www.iamj.in/posts/images/upload/2563_2569.pdf
  49. Singhal P. A comparative clinical study to evaluate the effect of indigenous compound drugs (shatavari mandoor and pippali ghrita) in parinama shoola vis-à-vis acid peptic disorders. International Journal of Ayurvedic Medicine. 2015; 6(3): 267–271p. Available from: https://www.ijam.co.in/index.php/ijam/article/view/06352015/327
  50. Anupama B, Nagendra P, Shankar GJ. Effect of Pippali Ghrita in Amlapitta (Urdvaga) – A Clinical Study. International Ayurvedic Medical Journal. 2015, 3(6): 1661–1671p. Available from: http://www.iamj.in/posts/2015/images/upload/1666_1671.pdf
  51. Suryavanshi SV. Prospective Interventional Study of Avipattikar Churna in relation with AMLAPITTA vyadhi. IOSR- Journal of Pharmacy and Biological Sciences. 2015; 10(4): 16–25p. Available from: https://www.iosrjournals.org/iosr-jpbs/papers/Vol10-issue4/Version-1/C01041pdf
  52. Chaturvedi GN, Rai NP, Dhani R, Tiwari SK. Clinical trial of adhatoda vasica syrup (vasa) in the patients of non-ulcer dyspepsia (amlapitta). Anc Sci Life. 1983; 3(1): 19–23p. Available from: https://pubmed.ncbi.nlm.nih.gov/22557371/
  53. Raj G, Dadhich OP, Yadav CR. Clinical evaluation of Eladi Churna and Yavadi Kwath in Amlapitta. International Ayurvedic Medical Journal. 2017; 5(6): 1856–1864p. Available from: http://www.iamj.in/posts/images/upload/1856_1864.pdf
  54. Singh R, KJ G, Mooss YN. Clinical Study on the Effectiveness of Pippali Khanda in the Management of Amlapitta. IJAM. 2017; 8(3): 128–133p. Available from: https://www.ijam.co.in/php/ijam/article/view/08222017.
  55. Ballester P, Cerdá B, Arcusa R, Marhuenda J, Yamedjeu K, Zafrilla P. Effect of Ginger on Inflammatory Diseases. Molecules. 2022; 27(21): 7223p. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654013/
  56. Chauhan K, Solanki R, Anar P, Carol M, Patel M. Phytochemical and Therapeutic potential of Piper longum Linn : A review. International Journal of Research in Ayurveda and P 2011; 2(21): 157–161p. Available from: https://www.researchgate.net/publication/275559341_Phytochemical_and_Therapeutic_potential_of_Piper_longum_Linn_A_review
  57. Saha S, Ghosh S. Tinospora cordifolia: One plant, many roles. Anc Sci Life. 2012; 31(4): 151–159p. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3644751/
  58. Yang Y. Chinese Herbal Formulas: Treatment Principles and Composition Strategies. United Kingdom: Churchill Livingstone Elsevier;
  59. Yifan Y. Theories and concepts of the composition of Chinese herbal formulas, Form of administration, preparation methods and their application. In: Chinese Herbal Formulas: Treatment Principles and Composition Strategies. UK: Elsevier Health Sciences; 2010. 12p.
Regular Issue Subscription Review Article
Volume 13
Issue 02
Received 04/12/2023
Accepted 27/05/2024
Published 21/06/2024
Total Visits: 308


My IP

PlumX Metrics